Fresenius | FRE - Assets


Fresenius reported EUR42.37B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Akzo Nobel EUR 16.13B 647M Jun/2026
Alcon AG USD 31.62B 64M Mar/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
BASF EUR 83.87B 2.1B Jun/2026
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
DaVita Healthcare Partners USD 17.71B 210.12M Jun/2026
Demant DKK 39.07B 6.43B Dec/2025
E.ON EUR 117.22B 6.53B Mar/2026
Essilor EUR 65.06B 1.16B Jun/2026
Fresenius EUR 42.37B 975M Mar/2026
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Getinge SEK 57.37B 6.55B Jun/2026
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
GN Store Nord DKK 28.56B 671M Mar/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 122.03B 3.5B Jun/2026
Philips EUR 26.7B 565M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
RWE EUR 116.76B 15.05B Mar/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Smith & Nephew USD 11.01B 321M Jun/2026